The Current Opinion journals were developed out of the recognition that it is increasingly difficult for specialists to keep up to date with the expanding volume of information published in their subject. Elsevier’s Current Opinion journals comprise of 26 leading titles in life sciences and adjacent fields.

Current Opinion in Pharmacology

IMPACT FACTOR: 6.313
5-Year Impact Factor: 5.384
Issues per year: 6 issues
Editorial Board

Current Opinion in Pharmacology

The Current Opinion journals were developed out of the recognition that it is increasingly difficult for specialists to keep up to date with the expanding volume of information published in their subject. In Current Opinion in Pharmacology, we help the reader by providing in a systematic manner:
1. The views of experts on current advances in pharmacology in a clear and readable form.
2. Evaluations of the most interesting papers, annotated by experts, from the great wealth of original publications

Division of the subject into sections
The subject of pharmacology is divided into themed sections, each of which is reviewed once a year. The amount of space devoted to each section is related to its importance.

NeurosciencesCardiovascular and renalRespiratoryMusculoskeletalCancerImmunomodulationAnti-infectives • New technologiesGastrointestinalEndocrine and metabolic diseases

Selection of topics to be reviewed
Section Editors, who are major authorities in the field, are appointed by the Editors of the journal. They divide their section into a number of topics, ensuring that the field is comprehensively covered and that all issues of current importance are emphasised. Section Editors commission reviews from authorities on each topic that they have selected.

Reviews
Authors write short review articles in which they present recent developments in their subject, emphasising the aspects that, in their opinion, are most important. In addition, they provide short annotations to the papers that they consider to be most interesting from all those published in their topic over the previous year.

Editorial Overview
Section Editors write a short overview at the beginning of the section to introduce the reviews and to draw the reader's attention to any particularly interesting developments.

Ethics in Publishing: General Statement

The Editor(s) and Publisher of this Journal believe that there are fundamental principles underlying scholarly or professional publishing. While this may not amount to a formal 'code of conduct', these fundamental principles with respect to the authors' paper are that the paper should: i) be the authors' own original work, which has not been previously published elsewhere, ii) reflect the authors' own research and analysis and do so in a truthful and complete manner, iii) properly credit the meaningful contributions of co-authors and co-researchers, iv) not be submitted to more than one journal for consideration, and v) be appropriately placed in the context of prior and existing research. Of equal importance are ethical guidelines dealing with research methods and research funding, including issues dealing with informed consent, research subject privacy rights, conflicts of interest, and sources of funding. While it may not be possible to draft a 'code' that applies adequately to all instances and circumstances, we believe it useful to outline our expectations of authors and procedures that the Journal will employ in the event of questions concerning author conduct. With respect to conflicts of interest, the Publisher now requires authors to declare any conflicts of interest that relate to papers accepted for publication in this Journal. A conflict of interest may exist when an author or the author's institution has a financial or other relationship with other people or organizations that may inappropriately influence the author's work. A conflict can be actual or potential and full disclosure to the Journal is the safest course. All submissions to the Journal must include disclosure of all relationships that could be viewed as presenting a potential conflict of interest. The Journal may use such information as a basis for editorial decisions and may publish such disclosures if they are believed to be important to readers in judging the manuscript. A decision may be made by the Journal not to publish on the basis of the declared conflict.

For more information, please refer to: http://www.elsevier.com/conflictsofinterest

Best Cited over the last year.

Subscribe to RSS Sciverse Scopus

PD-1/PD-L1 inhibitors

Volume 23, Issue , 03 June 2015, Pp 32-38
Joel Sunshine | Janis M. Taube

Resolution phase lipid mediators of inflammation: Agonists of resolution

Volume 13, Issue 4, 01 January 2013, Pp 632-640
Charles N. Serhan | Nan Chiang

Update on the antibiotic resistance crisis

Volume 18, Issue , 01 January 2014, Pp 56-60
Gian Maria Rossolini | Fabio Arena | Patrizia Pecile | Simona Pollini

Ocular perfusion pressure and ocular blood flow in glaucoma

Volume 13, Issue 1, 01 February 2013, Pp 36-42
A. Popa Cherecheanu | G. Garhofer | D. Schmidl | R. Werkmeister | L. Schmetterer

Oxidative stress and mitochondrial dysfunction in glaucoma

Volume 13, Issue 1, 01 February 2013, Pp 12-15
Vicki Chrysostomou | Fatemeh Rezania | Ian A. Trounce | Jonathan G. Crowston

Uncoupling of endothelial NO synthase in atherosclerosis and vascular disease

Volume 13, Issue 2, 01 April 2013, Pp 161-167
Huige Li | Ulrich Förstermann

Recent advances in osteosarcoma

Volume 16, Issue 1, 01 January 2014, Pp 15-23
Sander M. Botter | Dario Neri | Bruno Fuchs

Gut microbiota, enteroendocrine functions and metabolism

Volume 13, Issue 6, 25 September 2013, Pp 935-940
Patrice D. Cani | Amandine Everard | Thibaut Duparc

Superparamagnetic iron oxide nanoparticles for MR imaging and therapy: Design considerations and clinical applications

Volume 18, Issue , 01 January 2014, Pp 18-27
Rongrong Jin | Bingbing Lin | Danyang Li | Hua Ai

Drugging PI3K in cancer: Refining targets and therapeutic strategies

Volume 23, Issue , 26 June 2015, Pp 98-107
Timothy A. Yap | Lynn Bjerke | Paul A. Clarke | Paul Workman

Tumour-associated macrophages and cancer

Volume 13, Issue 4, 01 January 2013, Pp 595-601
Jenny Cook | Thorsten Hagemann

Schizophrenia: From dopaminergic to glutamatergic interventions

Volume 14, Issue 1, 01 February 2014, Pp 97-102
Marc Laruelle

Protein-protein interactions as druggable targets: Recent technological advances

Volume 13, Issue 5, 01 January 2013, Pp 791-796
Alicia P. Higueruelo | Harry Jubb | Tom L. Blundell

Light based anti-infectives: Ultraviolet C irradiation, photodynamic therapy, blue light, and beyond

Volume 13, Issue 5, 01 January 2013, Pp 731-762
Rui Yin | Tianhong Dai | Pinar Avci | Ana Elisa Serafim Jorge | Wanessa C.M.A. De Melo | Daniela Vecchio | Ying Ying Huang | Asheesh Gupta | Michael R. Hamblin

Transporters and receptors for short-chain fatty acids as the molecular link between colonic bacteria and the host

Volume 13, Issue 6, 28 November 2013, Pp 869-874
Vadivel Ganapathy | Muthusamy Thangaraju | Puttur D. Prasad | Pamela M. Martin | Nagendra Singh

The NMDA receptor 'glycine modulatory site' in schizophrenia: D-serine, glycine, and beyond

Volume 20, Issue , 01 January 2015, Pp 109-115
Darrick T. Balu | Joseph T. Coyle

Parathyroid hormone: Anabolic and catabolic actions on the skeleton

Volume 22, Issue , 01 January 2015, Pp 41-50
Barbara C. Silva | John P. Bilezikian

Cytokine targets in airway inflammation

Volume 13, Issue 3, 01 June 2013, Pp 351-361
Martijn J. Schuijs | Monique A. Willart | Hamida Hammad | Bart N. Lambrecht

New insights in the pathogenesis and treatment of normal tension glaucoma

Volume 13, Issue 1, 01 February 2013, Pp 43-49
Maneli Mozaffarieh | Josef Flammer

NMDA receptor subunit mutations in neurodevelopmental disorders

Volume 20, Issue , 01 January 2015, Pp 73-82
Nail Burnashev | Pierre Szepetowski

PI3K inhibitors in inflammation, autoimmunity and cancer

Volume 23, Issue , 19 June 2015, Pp 82-91
Anne Katrien Stark | Srividya Sriskantharajah | Edith M. Hessel | Klaus Okkenhaug

Enteroendocrine secretion of gut hormones in diabetes, obesity and after bariatric surgery

Volume 13, Issue 6, 24 October 2013, Pp 983-988
Jens Juul Holst

Targeting the HIF pathway in inflammation and immunity

Volume 13, Issue 4, 01 January 2013, Pp 646-653
Carsten C. Scholz | Cormac T. Taylor

Cachexia and sarcopenia: Mechanisms and potential targets for intervention

Volume 22, Issue , 13 June 2015, Pp 100-106
Josep M. Argilés | Silvia Busquets | Britta Stemmler | Francisco J. López-Soriano

Advances in the development of histone lysine demethylase inhibitors

Volume 23, Issue 1, 01 January 2015, Pp 52-60
Tamara Maes | Elena Carceller | Jordi Salas | Alberto Ortega | Carlos Buesa